Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieyuyihao
- Development stage
- Unknown
- Lead developer
- Beijing Anding Hospital
- Administration
- Oral
01
Overview
Jieyuyihao (also known as Jieyuyihao prescription or formula) is a Traditional Chinese Medicine (TCM) herbal preparation developed by Beijing Anding Hospital, affiliated with Capital Medical University. It is primarily indicated for the treatment of major depressive disorder (MDD), specifically targeting the TCM syndrome of "liver depression and qi stagnation." The formula is typically used as an adjunctive or additional treatment alongside standard psychiatric care. Clinical research, such as the trial registered under ChiCTR2300071009, focuses on evaluating its clinical efficacy in reducing depressive symptoms and investigating its potential neurobiological mechanisms using modern scientific methodologies.
- Brand names
- jieyuyihao
- Other names
- Jieyuyihao prescriptionJieyuyihao formulaJieyu Yihao
02
Targets
NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)BDNF (Brain-derived neurotrophic factor)SERT (Sodium-dependent serotonin transporter)CB (Cannabinoid receptors)
Beyond the preview
Go deeper on Jieyuyihao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jieyuyihao.